Thu, September 5, 2019
Wed, September 4, 2019
Tue, September 3, 2019
Fri, August 30, 2019

Paul Matteis Maintained (ACAD) at Hold with Increased Target to $28 on, Sep 3rd, 2019

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. with-increased-target-to-28-on-sep-3rd-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Paul Matteis of Stifel, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $24 to $28 on, Sep 3rd, 2019.

Paul has made no other calls on ACAD in the last 4 months.



There are 2 other peers that have a rating on ACAD. Out of the 2 peers that are also analyzing ACAD, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $40 on, Tuesday, August 27th, 2019
  • Danielle Brill of "Raymond James" Reiterated at Strong Buy with Increased Target to $43 on, Friday, May 31st, 2019